Australian middle-market private equity firm CPE has agreed to sell Cell Care, its cord blood banking business, to Generate Life Sciences, an American life sciences firm, for an undisclosed amount.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
